ArticleBMC medicine2025

A retrospective study evaluating the effect of trastuzumab addition to carboplatin/paclitaxel on overall survival in patients with advanced-stage HER2/neu-overexpressing uterine serous carcinoma or carcinosarcoma.

Ting-Fang Lu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.